- Pharmacologic management of Alzheimerdisease.
Overview Dementia is a major public health problem now estimated to affect about 5.1 million older adults in the United States and about 15 million worldwide. It is expected that there will be 13 million patients diagnosed with Alzheimer disease (AD) by the year 2050. The Alzheimer's Association anticipates that ......
- Psychiatry on the couch: Breakthroughs in brain
research could improve mental health care. (Society).
Two million Americans suffering from mental illnesses are not getting the care they need because the profession of psychiatry itself is in crisis over how to treat its patients, according to Harvard psychiatry professor J. Allan Hobson. Caregivers are not coordinating with each other, Hobson explains. Some therapists favor "humanistic" ......
- Pseudoscientific psychological therapies
scrutinized.
A symposium in the Spring 2001 issue of The Scientific Review of Alternative Medicine and Aberrant Medical Practices [SRAM] on "Pseudoscience and Psychotherapy" begins with brain behavior scientist Barry Beyerstein's article "Fringe Psychotherapies: The Public at Risk." Dr. Beyerstein notes three ways that fringe therapists endanger patients: (1) through manipulation ......
- Nursing care of patients with late-stage
Parkinson's disease.
Abstract: Patients in the late stages of Parkinson's disease may be significantly disabled for many years, often because of their increasing inability to tolerate therapeutic doses of antiparkinson drugs. Their status and management have been overlooked in the literature. Few current healthcare professionals have cared for patients with Parkinson's disease ......
- Pathophysiology and management of idiopathic
Parkinson's disease.
Introduction Parkinson's disease is a progressive degenerative disease of the nervous system which eventually leads to disability. Idiopathic parkinsonism refers to the presence of a characteristic constellation of symptoms, tremor, rigidity, bradykinesia and impairment of righting reflexes,[6] and pathologic changes, including the loss of pigmented neurons and the presence of ......
- Amyotrophic Lateral Sclerosis: Current
Understanding.
It was the eminent French neurologist Charcot who first described motor neuron disease (MND) in 1874 (Swash, 2000). Since his thorough and valid description, MND, or amyotrophic lateral sclerosis (ALS) as he termed it, remains an enigma (Mitsumoto, 1994). It is a degenerative disorder of the upper and lower motor ......
- Experiences of Critical Care Nurses Caring for
Unresponsive Patients.
Abstract: Grounded theory methodology was utilized to explore the experiences of critical care nurses caring for patients who were unable to respond due to a traumatic brain injury or receiving neuromuscular blocking agents. The registered nurses participating in the study worked in a neuroscience intensive care unit. Saturation of the ......